Your browser doesn't support javascript.

Biblioteca Virtual em Saúde

Brasil

Home > Pesquisa > ()
Imprimir Exportar

Formato de exportação:

Exportar

Email
Adicionar mais destinatários
| |

Discovery of orally efficacious RORγt inverse agonists. Part 2: Design, synthesis, and biological evaluation of novel tetrahydroisoquinoline derivatives.

Kono, Mitsunori; Oda, Tsuneo; Tawada, Michiko; Imada, Takashi; Banno, Yoshihiro; Taya, Naohiro; Kawamoto, Tetsuji; Tokuhara, Hidekazu; Tomata, Yoshihide; Ishii, Naoki; Ochida, Atsuko; Fukase, Yoshiyuki; Yukawa, Tomoya; Fukumoto, Shoji; Watanabe, Hiroyuki; Uga, Keiko; Shibata, Akira; Nakagawa, Hideyuki; Shirasaki, Mikio; Fujitani, Yasushi; Yamasaki, Masashi; Shirai, Junya; Yamamoto, Satoshi.
Bioorg Med Chem; 26(2): 470-482, 2018 01 15.
Artigo em Inglês | MEDLINE | ID: mdl-29258712
A series of tetrahydroisoquinoline derivatives were designed, synthesized, and evaluated for their potential as novel orally efficacious retinoic acid receptor-related orphan receptor-gamma t (RORγt) inverse agonists for the treatment of Th17-driven autoimmune diseases. We carried out cyclization of the phenylglycinamide core by structure-based drug design and successfully identified a tetrahydroisoquinoline carboxylic acid derivative 14 with good biochemical binding and cellular reporter activity. Interestingly, the combination of a carboxylic acid tether and a central fused bicyclic ring was crucial for optimizing PK properties, and the compound 14 showed significantly improved PK profile. Successive optimization of the carboxylate tether led to the discovery of compound 15 with increased inverse agonistic activity and an excellent PK profile. Oral treatment of mice with compound 15 robustly and dose-dependently inhibited IL-17A production in an IL23-induced gene expression assay.
Selo DaSilva